FRM
Fox Run Management’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-611
| Closed | -$225K | – | 986 |
|
|
2024
Q4 | $225K | Sell |
611
-574
| -48% | -$212K | 0.04% | 727 |
|
|
2024
Q3 | $616K | Buy |
1,185
+327
| +38% | +$170K | 0.14% | 273 |
|
|
2024
Q2 | $465K | Sell |
858
-1,524
| -64% | -$826K | 0.09% | 434 |
|
|
2024
Q1 | $1.24M | Buy |
+2,382
| New | +$1.24M | 0.27% | 76 |
|
|
2023
Q4 | – | Sell |
-2,515
| Closed | -$1.1M | – | 799 |
|
|
2023
Q3 | $1.1M | Buy |
+2,515
| New | +$1.1M | 0.32% | 53 |
|
|
2022
Q4 | – | Sell |
-1,466
| Closed | -$666K | – | 694 |
|
|
2022
Q3 | $666K | Buy |
+1,466
| New | +$666K | 0.26% | 89 |
|
|
2022
Q1 | – | Sell |
-580
| Closed | -$269K | – | 554 |
|
|
2021
Q4 | $269K | Buy |
+580
| New | +$269K | 0.16% | 268 |
|
|
2021
Q2 | – | Sell |
-702
| Closed | -$252K | – | 373 |
|
|
2021
Q1 | $252K | Buy |
+702
| New | +$252K | 0.45% | 113 |
|
|
2020
Q3 | – | Sell |
-1,534
| Closed | -$403K | – | 219 |
|
|
2020
Q2 | $403K | Buy |
+1,534
| New | +$403K | 0.53% | 39 |
|
|
2019
Q2 | – | Sell |
-883
| Closed | -$253K | – | 476 |
|
|
2019
Q1 | $253K | Buy |
+883
| New | +$253K | 0.14% | 325 |
|
|
2018
Q4 | – | Sell |
-1,447
| Closed | -$397K | – | 566 |
|
|
2018
Q3 | $397K | Sell |
1,447
-778
| -35% | -$213K | 0.17% | 262 |
|
|
2018
Q2 | $530K | Buy |
2,225
+118
| +6% | +$28.1K | 0.17% | 223 |
|
|
2018
Q1 | $463K | Buy |
+2,107
| New | +$463K | 0.11% | 336 |
|